Stay updated on Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial

Sign up to get notified when there's something new on the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.3.4 added and v3.3.3 removed; changes are limited to revision metadata and do not affect study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T00:46:08.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure and Revision: v3.3.2 notices. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T07:40:35.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.3.1 to v3.3.2. No study content, eligibility criteria, outcomes, or other critical information was changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:27:56.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page shows a minor site revision update: addition of Revision: v3.3.1 and removal of Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:57:32.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice; the page no longer displays an administrative banner about funding status, which does not impact the study details or how a user interacts with the page.
    Difference
    0.4%
    Check dated 2025-11-17T06:19:51.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page changes appear to be cosmetic UI/layout updates to the study record; core content such as the study title, conditions, eligibility criteria, and outcomes remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:56:34.000Z thumbnail image

Stay in the know with updates to Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page.